KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Payables (2016 - 2025)

Historic Payables for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $5.4 billion.

  • Eli Lilly's Payables rose 1756.61% to $5.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.4 billion, marking a year-over-year increase of 1756.61%. This contributed to the annual value of $5.4 billion for FY2025, which is 1756.61% up from last year.
  • Eli Lilly's Payables amounted to $5.4 billion in Q4 2025, which was up 1756.61% from $4.3 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Payables ranged from a high of $5.4 billion in Q2 2025 and a low of $1.4 billion during Q1 2022
  • Its 5-year average for Payables is $3.0 billion, with a median of $2.7 billion in 2021.
  • As far as peak fluctuations go, Eli Lilly's Payables skyrocketed by 8991.34% in 2021, and later crashed by 1258.23% in 2022.
  • Quarter analysis of 5 years shows Eli Lilly's Payables stood at $2.6 billion in 2021, then rose by 15.32% to $2.9 billion in 2022, then grew by 27.82% to $3.8 billion in 2023, then increased by 21.43% to $4.6 billion in 2024, then grew by 17.57% to $5.4 billion in 2025.
  • Its last three reported values are $5.4 billion in Q4 2025, $4.3 billion for Q3 2025, and $5.4 billion during Q2 2025.